Home
About
Overview
Sharing Data
ORCID
Help
History (34)
Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells.
Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study.
Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.
Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.
Patient Characteristics Associated with More Bother from Lower Urinary Tract Symptoms.
See All 34 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Patient Characteristics Associated with More Bother from Lower Urinary Tract Symptoms.
Patient Characteristics Associated with More Bother from Lower Urinary Tract Symptoms. J Urol. 2019 09; 202(3):585-591.
View in:
PubMed
subject areas
Adult
Aged
Female
Humans
Lower Urinary Tract Symptoms
Male
Middle Aged
Prospective Studies
Self Report
Severity of Illness Index
Sex Factors
Stress, Psychological
authors with profiles
Kimberly Kenton
Margaret Mueller
James Griffith